Skip to main content

An official website of the United States government

You have 2 new alerts

JPEO-CBRND & BARDA Commercial Solutions Opening (CSO) Area of Interest (AoI) W911QY-20-S-C001-A004 SARS-CoV-2 Industrial Base Expansion (IBX)

info alert

Note: There have been new actions to this contract opportunity. To view the most recent action, please click here.

Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information

  • Contract Opportunity Type: Solicitation (Updated)
  • Updated Published Date: Dec 17, 2021 04:37 pm EST
  • Original Published Date:
  • Requirements Strategy:
  • Inactive Policy: 15 days after date offers due
  • Updated Inactive Date: Feb 01, 2022
  • Original Inactive Date:
  • Authority:
  • Fair Opportunity / Limited Sources Justification Authority:
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code:
  • NAICS Code:
  • Place of Performance:

Description

Under the President’s COVID-19 Countermeasures Acceleration Group, Health and Human Services is leading a whole of nation effort with the primary goal to execute on a well-defined portfolio of COVID-19 medical countermeasure (MCM) candidates to maximize probability of having safe and effective diagnostics, therapeutics, and vaccines as fast as possible for mass distributions. The current COVID-19 pandemic response exposed the limited availability of the consumables (and the raw materials to make them) that are required to manufacture COVID-19 MCM and the fragility of the global supply chain. Increasing the availability of these consumables, including the raw materials required to make them, within the continental US is critical to national security and ongoing domestic manufacturing of COVID-19 vaccines, therapeutics, and diagnostics. As such, The Biomedical Advanced Research and Development Authority (BARDA) has an Area of Interest (AoI) for innovative commercial products, technologies, or services that establish, expand, and/or accelerate domestic supply of consumables and domestic manufacturing capabilities related to MCMs.

Contact Information

Primary Point of Contact

Secondary Point of Contact

History